Annual CFF
$116.14 M
-$87.11 M-42.86%
December 31, 2024
Summary
- As of March 12, 2025, MLYS annual cash flow from financing activities is $116.14 million, with the most recent change of -$87.11 million (-42.86%) on December 31, 2024.
- During the last 3 years, MLYS annual CFF has risen by +$92.33 million (+387.75%).
- MLYS annual CFF is now -42.86% below its all-time high of $203.25 million, reached on December 31, 2023.
Performance
MLYS Cash From Financing Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly CFF
$90.00 K
+$91.00 K+9100.00%
December 31, 2024
Summary
- As of March 12, 2025, MLYS quarterly cash flow from financing activities is $90.00 thousand, with the most recent change of +$91.00 thousand (+9100.00%) on December 31, 2024.
- Over the past year, MLYS quarterly CFF has increased by +$16.00 thousand (+21.62%).
- MLYS quarterly CFF is now -99.96% below its all-time high of $203.57 million, reached on March 31, 2023.
Performance
MLYS Quarterly CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM CFF
$116.14 M
+$16.00 K+0.01%
December 31, 2024
Summary
- As of March 12, 2025, MLYS TTM cash flow from financing activities is $116.14 million, with the most recent change of +$16.00 thousand (+0.01%) on December 31, 2024.
- Over the past year, MLYS TTM CFF has dropped by -$87.11 million (-42.86%).
- MLYS TTM CFF is now -63.66% below its all-time high of $319.59 million, reached on March 31, 2023.
Performance
MLYS TTM CFF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Cash From Financing Formula
CFF = Cash Inflows from Financing Activities − Cash Outflows from Financing Activities
MLYS Cash From Financing Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -42.9% | +21.6% | -42.9% |
| 3 y3 years | +387.8% | +21.6% | -42.9% |
| 5 y5 years | +2932.4% | +21.6% | -42.9% |
MLYS Cash From Financing Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -42.9% | +387.8% | -100.0% | +108.4% | -63.7% | +868.1% |
| 5 y | 5-year | -42.9% | +2932.4% | -100.0% | +108.4% | -63.7% | +868.1% |
| alltime | all time | -42.9% | +2932.4% | -100.0% | +108.4% | -63.7% | +868.1% |
Mineralys Therapeutics Cash From Financing History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Dec 2024 | $116.14 M(-42.9%) | $90.00 K(-9100.0%) | $116.14 M(+0.0%) |
| Sep 2024 | - | -$1000.00(-99.3%) | $116.13 M(-0.2%) |
| Jun 2024 | - | -$152.00 K(-100.1%) | $116.31 M(+0.4%) |
| Mar 2024 | - | $116.20 M(>+9900.0%) | $115.88 M(-43.0%) |
| Dec 2023 | $203.25 M | $74.00 K(-59.8%) | $203.25 M(+0.6%) |
| Sep 2023 | - | $184.00 K(-131.7%) | $202.11 M(+0.4%) |
| Jun 2023 | - | -$581.00 K(-100.3%) | $201.36 M(-37.0%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2023 | - | $203.57 M(<-9900.0%) | $319.59 M(+149.6%) |
| Dec 2022 | $128.02 M(+437.6%) | -$1.07 M(+90.4%) | $128.02 M(-0.8%) |
| Sep 2022 | - | -$561.00 K(-100.5%) | $129.09 M(-0.4%) |
| Jun 2022 | - | $117.65 M(+880.7%) | $129.65 M(+980.7%) |
| Mar 2022 | - | $12.00 M | $12.00 M |
| Dec 2021 | $23.81 M(+521.7%) | - | - |
| Dec 2020 | $3.83 M | - | - |
FAQ
- What is Mineralys Therapeutics annual cash flow from financing activities?
- What is the all time high annual CFF for Mineralys Therapeutics?
- What is Mineralys Therapeutics annual CFF year-on-year change?
- What is Mineralys Therapeutics quarterly cash flow from financing activities?
- What is the all time high quarterly CFF for Mineralys Therapeutics?
- What is Mineralys Therapeutics quarterly CFF year-on-year change?
- What is Mineralys Therapeutics TTM cash flow from financing activities?
- What is the all time high TTM CFF for Mineralys Therapeutics?
- What is Mineralys Therapeutics TTM CFF year-on-year change?
What is Mineralys Therapeutics annual cash flow from financing activities?
The current annual CFF of MLYS is $116.14 M
What is the all time high annual CFF for Mineralys Therapeutics?
Mineralys Therapeutics all-time high annual cash flow from financing activities is $203.25 M
What is Mineralys Therapeutics annual CFF year-on-year change?
Over the past year, MLYS annual cash flow from financing activities has changed by -$87.11 M (-42.86%)
What is Mineralys Therapeutics quarterly cash flow from financing activities?
The current quarterly CFF of MLYS is $90.00 K
What is the all time high quarterly CFF for Mineralys Therapeutics?
Mineralys Therapeutics all-time high quarterly cash flow from financing activities is $203.57 M
What is Mineralys Therapeutics quarterly CFF year-on-year change?
Over the past year, MLYS quarterly cash flow from financing activities has changed by +$16.00 K (+21.62%)
What is Mineralys Therapeutics TTM cash flow from financing activities?
The current TTM CFF of MLYS is $116.14 M
What is the all time high TTM CFF for Mineralys Therapeutics?
Mineralys Therapeutics all-time high TTM cash flow from financing activities is $319.59 M
What is Mineralys Therapeutics TTM CFF year-on-year change?
Over the past year, MLYS TTM cash flow from financing activities has changed by -$87.11 M (-42.86%)